Previous 10 | Next 10 |
AngioSoma (SOAN) announces the appointment of Brooke Greenwald as the company's Chief Marketing Officer.Greenwald has more than three decades of experience in marketing and public relations, and has held leadership positions in multiple healthcare organizations and is an a...
Greenwald's experience in public relations and marketing will play a key role in the growth of AngioSoma RICHLAND, WA / ACCESSWIRE / April 19, 2021 / AngioSoma, Inc. (OTC PINK:SOAN) has hired Brooke Greenwald as its Chief Marketing Officer. Ms. Greenwald brings decades of experience spe...
AngioSoma (SOAN) through its wholly-owned subsidiary, SomaCeuticals, announces that the Exclusive Global Multiple Sclerosis License Agreement dated August 23, 2020 has been amended and restated as of February 4, 2021.The amended agreement will give both parties a stronger platform to market a...
Houston, TX, Feb. 11, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- AngioSoma Inc. ( OTC : SOAN) (“ AngioSoma ” or the “ Company ”), through its wholly-owned subsidiary, SomaCeuticals, Inc., is pleased to announce that the ...
Houston, TX, Aug. 24, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- AngioSoma Inc. ( OTC : SOAN) (“ AngioSoma ” or the “ Company ”) is pleased to announce that the company’s subsidiary, SomaCeuticals, Inc., has executed a licensing agreement...
AngioSoma ( OTCPK:SOAN +8.3% ) announced that the company’s subsidiary, SomaCeuticals has elected James C. Katzaroff as President to serve until his successor is elected and qualified. More news on: AngioSoma, Inc., Advanced Medical Isotope Corp., Read more ...
Houston, TX, Aug. 17, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- AngioSoma Inc. ( OTC : SOAN) (“ AngioSoma ” or the “ Company ”) is pleased to announce that the company’s subsidiary, SomaCeuticals, Inc., has elected James C. Katzaroff a...
Houston, TX, May 27, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- AngioSoma, Inc. ( OTC : SOAN) (“ AngioSoma ” or the “ Company ”) is pleased to announce that the Company is focusing on development and commercialization of our coating for metal stent...
Houston, TX, May 20, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- AngioSoma Inc. ( OTC : SOAN) (“ AngioSoma ” or the “ Company ”) is pleased to announce that the Company’s peripheral arterial disease (“PAD”) product, Atherec...
Houston, TX, April 21, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- AngioSoma Inc. ( OTC : SOAN) (“ AngioSoma ” or the “ Company ”) today announced that holders of the Company's 12% unsecured convertible notes in the total principal amount of $68,000...
News, Short Squeeze, Breakout and More Instantly...
First Titan Company Name:
SOAN Stock Symbol:
OTCMKTS Market:
FINRA Approval for the AngioSoma name change is effective immediately. RICHLAND, WA / ACCESSWIRE / July 6, 2021 / AngioSoma, Inc. (OTC PINK:SOAN) is now officially GlobeStar Therapeutics Corporation (OTC PINK:GSTC). This announcement is effective immediately and the market effective ...
Srinivasan's medical management experience, leadership positions, and advisory experience will add additional depth to the AngioSoma team. RICHLAND, WA / ACCESSWIRE / July 1, 2021 / AngioSoma, Inc. (OTC PINK:SOAN) has added Kaushik Srinivasan, CEO, Radiant Health, to the Advisory Board....
Dr. Lewis's medical experience and research background will play a significant role in AngioSoma. RICHLAND, WA / ACCESSWIRE / June 22, 2021 / AngioSoma, Inc. (OTC PINK:SOAN) has added Dr. Michael Lewis, MD, to the Medical Advisory Board. Dr. Lewis's experience in frontier sciences, pati...